Here are eight things for spinal surgeons to know for Aug. 3, 2017.
Medtronic completes $6.1B sale of a fraction of patient monitoring & recovery division businesses to Cardinal Health
Medtronic completed the sale of its patient care, deep vein thrombosis and nutritional insufficiency business within its minimally invasive therapies group's patient monitoring and recovery division. The company sold the business to Cardinal Health for $6.1 billion in cash. Medtronic expects a modest dilution on a net basis to the fiscal year 2018 non-GAAP earnings per share of around $0.18 from the sale.
Patient's husband shoots, kills South Bend Orthopaedics physician who wouldn't prescribe opioids
Todd A. Graham, MD, was fatally shot in the parking lot of at Saint Joseph Health Rehabilitation Institute in Mishawaka, Ind., after declining to prescribe opioids to a patient, the South Bend Tribune reports. Read more about the story here.
Texas Spine & Joint Hospital now under Baylor Scott & White Health umbrella
On Aug. 1, Baylor Scott & White Holdings acquired a majority stake in Texas Spine & Joint Hospital, according to Tyler Morning Telegraph. United Surgical Partners International, a partner of Baylor Scott & White, is also a player in the partnership and will serve in a management role. The Texas Spine & Joint Hospital will now operate within the Baylor Scott & White system, but will be partially physician-owned.
Washington jury awards patient $1.2M for negligent spine surgery
A Washington jury ruled in favor of a patient injured during a spine surgery. The jury awarded the plaintiff $1.2 million in the medical malpractice case, finding Michael Thomas, DO, of Yakima, Wash.-based Cascade Neurosurgical Associates, negligently performed spine surgery on the patient that resulted in severe spinal deformity for three years.
Mazor Robotics sells 14 Mazor X systems in Q2, revenue jumps 87% to $15.5M
Mazor Robotics reported an 87 percent increase in second quarter revenue. Revenue hit $15.5 million in the second quarter of 2017, driven by a 110 percent increase in U.S. revenue compared to the same period last year. The company sold 14 Mazor X systems during the quarter. Mazor ended the quarter with a 14-system backlog and expects to ship those systems in the third quarter.
InVivo Therapeutics reports INSPIRE study updates; reports 1 death unrelated to study
InVivo Therapeutics reported a patient improved from complete AIS A SCI to motor incomplete AIS C SCI, when examined at the one-month visit. Additionally, the company is temporarily halting patient enrollment in the INSPIRE study, following a patient death. The most recent patient implanted with the Neuro-Spinal Scaffold in late June died at a rehabilitation facility after discharge from the hospital. The site's principal investigator reported the cause of death was not related to the Neuro-Spinal Scaffold or implantation procedure.
Zimmer Biomet reports $1.9B Q2 sales
Zimmer Biomet reported slight sales growth in the second quarter of 2017. Net sales were $1.9 billion, a 1.1 percent year-over-year increase. However, excluding the contributions from LDR — a spine-focused device company Zimmer Biomet acquired last year — net sales dropped 1.3 percent. The company expects revenue to reach $7.8 billion to $7.87 billion for the full year, a 1.8 percent to 2.7 percent growth over 2016.
NuVasive loses COO, CFO amid organizational restructuring
NuVasive's President and COO Jason Hannon is stepping down from his roles with the company after 12 years and the company announced organizational restructuring which will take effect Aug. 1. The company's CFO Quentin Blackford resigned effective Aug. 25 in an unrelated matter to pursue an opportunity outside of the spine industry.